Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

ROTA.shock Outcomes: Intravascular Lithotripsy vs. Rotational Atherectomy

At present, severe calcified coronary stenosis poses a significant challenge for PCI. A successful intervention will require plaque modification prior stenting, seeing as sub-expansion has been associated with worse clinical outcomes at followup. 

The tools normally used to treat these complex lesions include specialized balloons such as cutting, scoring, and high pressure balloons, as well as rotational (RA) and orbital atherectomy. However, these last two methods have limited effect in deep calcifications and have been associated with periprocedural complications, such as MI, perforation, atrioventricular blockage and no reflow or slow flow phenomenon. 

Intravascular Lithotripsy (IVL) has been recently introduced as an additional therapeutic alternative. To date, there are no randomized studies to compare RA vs IVL in the treatment of calcified coronary lesions. 

The aim of this prospective, multicenter, non-inferiority study was to compare IVL against RA in terms of plaque modification, stent area and lumen gain, assessed by optical coherence tomography (OCT).

Read also: Post-TAVI Prosthesis-Patient Mismatch.

Primary end point was post procedural minimal stent area (MSA). Secondary end points included mean stent diameter, minimal lumen diameter, mean lumen diameter, minimal lumen area, mean lumen area, mean stent area, minimal stent diameter, stent expansion, eccentricity, fracture, malapposition, troponin levels, procedural time, contrast consumption, radiation dose, target vessel failure (TLF) and target lesion revascularization (TLR) both inhospital and at 1 and 6 month followup. 

In total, the study included 70 patients between 2019 and 2021, who were randomized 1:1. Mean age was 73, and most were men. Stable coronary heart disease was the most common clinical presentation (82%), followed by non ST elevation MI (9.8%), unstable angina (3.3%) and ST acute MI (1.5%). The right coronary artery was treated most often.  The transradial was the most used access site (65.6% while the femoral was used in 37.7% of cases). Predilation was most frequently done in the IVL arm (60% of cases, P= 0.04). There were no significant differences between groups as regards contrast consumption, radiation dose and procedural time. 

Primary end point of MSA resulted similar between groups, though slightly lower in IVL patients (mean: 6.10 mm2, 95% CI: 5.32–6.87 mm2) vs. RA (mean: 6.60 mm2, 95% CI: 5.66–7.54 mm2). 

Read also: Predictors and Evolution of Need for PPM after TAVR with Self-Expanding Valves.

Also, there were no significant differences as regards stent dimension and lumen. However, there was a tendency towards larger stent area with RA vs. IVL (9.52 ± 3.01 mm2 vs. 8.55 ± 2.31 mm2; p = 0.13). There were no differences in stent expansion, malapposition, tissue prolapse or fracture. Lastly, there were no differences in clinical outcomes. 

Conclusion

The use of IVL was shown non-inferior in terms of MSA and stent expansion vs. RA. Also, there were no significant differences in technique induced periprocedural myocardial damage. IVL appears to be an effective therapeutic alternative to approach severely calcified coronary lesions.

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.

Reference: F. Blachutzik MD et al Catheter Cardiovasc Interv. 2023;1–11. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...